Abstract:Glioblastoma (GBM) is the most common malignant primary tumor in the human central nervous system. The present study aimed to explore the molecular mechanism by which microRNA (miR)-181a-5p targets the F-box protein 11 (FBXO11) in glioma cells to inhibit cell proliferation and invasion. Reverse transcription-quantitative (RT-q)PCR was performed to detect the expression levels of miR-181a-5p in U251TR cells, U251 cells, primary GBM tissues and relapsed GBM tissues in order to determine the association between miR-181a-5p and the chemoresistance of GBM cells. The expression levels of miR-181a-5p in GBM cells were modulated via transfecting miR-181a-5p mimics and inhibitors. Cell Counting Kit-8 assays were undertaken to assess the effects of miR-181a-5p on drug sensitivity and proliferation of GBM cells. Wound healing assays were performed to examine the effects of miR-181a-5p on the migratory ability of GBM cells. Furthermore, the effects of miR-181a-5p on the invasive ability of GBM cells were analyzed using an in vitro invasion assay. Flow cytometry analysis was carried out to determine whether overexpression of miR-181a-5p can promote the apoptotic rate of GBM cells. RT-qPCR and western blotting were employed to detect the effects of miR-181a-5p on mRNA and protein expression of FBX011. miR-181a-5p exhibited low expression in resistant GBM cell lines and recurrent tumor tissues. Dual-luciferase reporter assays were utilized to detect luciferase activity to verify the targeted regulatory association between miR-181a-5p and FBXO11. Upregulation of miR-181a-5p promoted the sensitivity of GBM cells to temozolomide (TMZ), increased the apoptotic rate of GBM cells and significantly inhibited the invasive and migratory capacities of GBM cells. In drug-resistant glioma cells, compared with the miR-negative control group and the blank group, the expression of miR-181a-5p was significantly upregulated (P<0.01), while the expression of FBXO11 protein was downregulated. miR-181a-5p increased the sensitivity of GBM cells to TMZ. miR-181a-5p significantly inhibited the migratory and invasive capacities of GBM cells. miR-181a-5p may become a novel effective target for the treatment of GBM. The results of dual-luciferase reporter assays indicated that miR-181a-5p could target the 3'-untranslated region of FBXO11. The underlying mechanism may be targeted inhibition of FBXO11 gene expression, or may be associated with apoptosis.

Identification of Mirna-7 by Genome-Wide Analysis As a Critical Sensitizer for TRAIL-induced Apoptosis in Glioblastoma Cells.

MicroRNA-7: A critical sensitizer for TRAIL sensitivity in glioblastoma cells

A miR-137-XIAP axis contributes to the sensitivity of TRAIL-induced cell death in glioblastoma

Identification of the Role of TRPM8 in Glioblastoma and Its Effect on Proliferation, Apoptosis and Invasion of the U251 Human Glioblastoma Cell Line

A Predicted Mir-27A-mediated Network Identifies a Signature of Glioma.

Identify Signature Regulatory Network for Glioblastoma Prognosis by Integrative Mrna and Mirna Co-Expression Analysis.

Targeting Micrornas to Modulate TRAIL-induced Apoptosis of Cancer Cells

Mir-138-5p Suppresses Glioblastoma Cell Viability and Leads to Cell Cycle Arrest by Targeting Cyclin D3.

MiR-7-5p suppresses stemness and enhances temozolomide sensitivity of drug-resistant glioblastoma cells by targeting Yin Yang 1

Mir-133A Promotes TRAIL Resistance in Glioblastoma Via Suppressing Death Receptor 5 and Activating NF-κB Signaling

miR-708 acts as a tumor suppressor in human glioblastoma cells.

Breast Cancer-Specific TRAIL Expression Mediated by Mirna Response Elements of Let-7 and Mir-122.

Mir-146B-5p Suppresses Glioblastoma Cell Resistance to Temozolomide Through Targeting TRAF6

The Effect Of Mir-7 On Behavior And Global Protein Expression In Glioma Cell Lines

In Silico Analysis Identified Mirna-Based Therapeutic Agents Against Glioblastoma Multiforme

MiR-181b sensitizes glioma cells to teniposide by targeting MDM2

Identification of Six N7-Methylguanosine-Related Mirna Signatures to Predict the Overall Survival and Immune Landscape of Triple-Negative Breast Cancer Through in Silico Analysis

MicroRNAs involved in the EGFR pathway in glioblastoma

Mir-181A-5p Inhibits the Proliferation and Invasion of Drug-Resistant Glioblastoma Cells by Targeting F-box Protein 11 Expression

Stepwise Detection and Evaluation Reveal Mir-10B and Mir-222 As a Remarkable Prognostic Pair for Glioblastoma.

MiR-9 Promotes Apoptosis Via Suppressing SMC1A Expression in GBM Cell Lines.